A “breakthrough” new three-drug combination offers hope for women battling an aggressive form of breast cancer, potentially ...

Using the ‘golden key’ to identify suitable patients, the results from the trial indicate that deaths could be cut by a third ...

The treatment could also delay the need for gruelling chemotherapy, according to the trial. | ITV National News ...

A new three-drug combination could help women with a common form of aggressive breast cancer live longer, research suggests - ...

Among patients with ESR1-mutant, ER+, HER2– advanced breast cancer, vepdegestrant improved survival without progression when ...

A new three-drug combination could help women with a common form of aggressive breast cancer live longer, a study has ...